0001209191-20-057330.txt : 20201106 0001209191-20-057330.hdr.sgml : 20201106 20201106173848 ACCESSION NUMBER: 0001209191-20-057330 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201104 FILED AS OF DATE: 20201106 DATE AS OF CHANGE: 20201106 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kamal Mostafa CENTRAL INDEX KEY: 0001647234 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-06639 FILM NUMBER: 201295467 MAIL ADDRESS: STREET 1: 15950 NORTH 76TH STREET, #200 CITY: SCOTTSDALE STATE: AZ ZIP: 85260 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MAGELLAN HEALTH INC CENTRAL INDEX KEY: 0000019411 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOSPITALS [8060] IRS NUMBER: 581076937 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4801 E. WASHINGTON ST CITY: PHOENIX STATE: AZ ZIP: 85034 BUSINESS PHONE: 800-642-1716 MAIL ADDRESS: STREET 1: 4801 E. WASHINGTON ST CITY: PHOENIX STATE: AZ ZIP: 85034 FORMER COMPANY: FORMER CONFORMED NAME: MAGELLAN HEALTH SERVICES INC DATE OF NAME CHANGE: 19960226 FORMER COMPANY: FORMER CONFORMED NAME: CHARTER MEDICAL CORP DATE OF NAME CHANGE: 19920703 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-11-04 0 0000019411 MAGELLAN HEALTH INC MGLN 0001647234 Kamal Mostafa 4801 EAST WASHINGTON STREET PHOENIX AZ 85034 0 1 0 0 CEO, Magellan Rx Management Ordinary Common Stock, $0.01 par value 2020-11-04 4 X 0 3434 64.87 A 9051 D Ordinary Common Stock, $0.01 par value 2020-11-04 4 S 0 3434 79.8925 D 5617 D Ordinary Common Stock, $0.01 par value 2020-11-05 4 X 0 3589 64.87 A 9206 D Ordinary Common Stock, $0.01 par value 2020-11-05 4 S 0 3589 79.87 D 5617 D Stock Option (right to buy) 64.87 2020-11-04 4 X 0 3434 0.00 D 2026-03-03 Common Stock 3434 3589 D Stock Options (right to buy) 64.87 2020-11-05 4 X 0 3589 0.00 D 2026-03-03 Common Stock 3589 0 D This transaction was effectuated pursuant to a Rule 10b-5-1 Plan. The number of securities reported represents an aggregate number of shares sold in multiple open market transactions at an average price of $79.8925. The price reported represents the weighted average price. The Reporting Person undertakes to provide staff of the SEC, the issuer, or a stockholder of the issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range. All of the stock options in this tranche have vested in full. Not applicable. This transaction was effectuated pursuant to a Rule 10b-5-1 Plan. /s/ Mostafa Kamal 2020-11-06